Mitochondrial Trifunctional Protein Deficiency due to HADHA Variants Masquerading as Charcot–Marie–Tooth Disease
Journal of the Peripheral Nervous System · 2025
DOI: 10.1111/jns.70048 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Farkhanda Qaiser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tallaght University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Mitochondrial Trifunctional Protein, alpha Subunit, Lipid Metabolism, Inborn Errors, Mitochondrial Trifunctional Protein. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Mitochondrial trifunctional protein deficiency (MTPD) is an inherited disorder of fatty acid β‐oxidation caused by mutations in HADHA or HADHB genes. It typically presents with cardiomyopathy or hepatic failure in early childhood; however, it may rarely present in adulthood with the neuromyopathic form.
Methods
We describe a patient with MTPD with isolated neuropathy mimicking Charcot–Marie–Tooth disease (CMT) as the first and only presenting symptom. Clinical and electrophysiological examinations were conducted, including nerve conduction studies, needle electromyography, muscle and nerve biopsies. The diagnosis was confirmed with genetic testing and enzymatic analysis of cultured skin fibroblasts.
Results
We report a 40‐year‐old man diagnosed with axonal CMT2 in childhood. He had pes cavus and hammer toes, mild distal lower limb weakness, and loss of vibration sense with areflexia. He later developed fatigability, improved exercise tolerance with alcohol and an episode of chest infection causing neurological decompensation without evidence of rhabdomyolysis. Neurophysiology showed non‐length‐dependent axonal sensorimotor neuropathy without myopathic features. Genetic testing confirmed that he was compound heterozygous for two HADHA variants, one of them novel, and enzymatic analysis of cultured skin fibroblasts confirmed MTPD.
Interpretation
We report a very rare isolated neuropathic phenotype of MTPD and confirm the pathogenicity of the novel variant c.1003G>A, p.(Glu335Lys). This case also highlights the need for HADHA and HADHB to be included in neuropathy gene panels as MTPD may present as CMT. Given that dietary management may prevent some complications of MTPD, achieving a diagnosis early is important.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tallaght University Hospital, Dublin, Ireland.
- Department of Neurophysiology, Tallaght University Hospital, Dublin, Ireland.
- Department of Neurophysiology, Beaumont Hospital, Dublin, Ireland.
- Department of Neuropathology, Beaumont Hospital, Dublin, Ireland.
- National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital, Eccles St., Dublin, Ireland.
- School of Public Health, University College Dublin, Dublin, Ireland.
ORCID-Profile: Farkhanda Qaiser, Loai Shakerdi
Zitieren
APA
Qaiser, F., McHugh, J., Mullins, G., Farrell, M., Shakerdi, L., Byrne, J. O., & Murphy, S. M. (2025). Mitochondrial Trifunctional Protein Deficiency due to HADHA Variants Masquerading as Charcot–Marie–Tooth Disease. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70048
Vancouver
Qaiser F, McHugh J, Mullins G, Farrell M, Shakerdi L, Byrne JO, et al. Mitochondrial Trifunctional Protein Deficiency due to HADHA Variants Masquerading as Charcot–Marie–Tooth Disease. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70048
BibTeX
@article{Qaiser2025,
author = {Qaiser, Farkhanda and McHugh, John and Mullins, Gerard and Farrell, Michael and Shakerdi, Loai and Byrne, James O and Murphy, Sinéad M},
title = {Mitochondrial Trifunctional Protein Deficiency due to HADHA Variants Masquerading as Charcot–Marie–Tooth Disease},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
doi = {10.1111/jns.70048}
}
EUVIMED